Stifel Nicolaus analyst Paul Matteis maintained a Buy rating on Neurogene (NGNE – Research Report) today and set a price target of $46.00. The company’s shares closed last Friday at $20.46 ...

In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Disc Medicine (IRON – Research Report), with a price target of $94.00. The company’s shares closed ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...

A long-time casting director-cum-acting coach is hoping to offer a fresh perspective for actors whose confidence may have been shaken after watching a viral interview with an Atlanta casting ...

Exceptional Long Casting Performance - The Magic Shadow baitcasting fishing rod ensures exceptional long-distance casting with its mod-fast action design, balancing distance and sensitivity for ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

However, some recently resurfaced social media posts have cast a shadow over the Spanish-language crime drama and musical. Star Karla Sofía Gascón has faced criticism for several past social ...

ST. LOUIS, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Stifel Financial Corp. (NYSE: SF) today reported net revenues of $1.36 billion for the three months ended December 31, 2024, compared with $1.15 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...